Comments to FDA: Proposed Rule for Sunscreen Drug Products for OTC Human Use

Share page:

Comments | Jun 27, 2019

Docket Number:
FDA-1978-N-0018

These comments are submitted as supporting evidence for the safety of the spray dosage from of sunscreens and is referenced in the comments filed to this docket by PCPC and CHPA.

Related Posts

Press Releases and Statements

CHPA Welcomes Three Consumer Healthcare Industry Members

Press Releases and Statements

CHPA Statement: OTC Pain Relievers and COVID-19 Vaccines